David B. Abramowitz
Buchanan Ingersoll & RooneyGeneral
Experience19 yrs
Elite Ratings
--
Practice Areas
Chemical Biotech (2 cases)
Biotech (87 cases)
Chemical (3 cases)
Communications (2 cases)
Transport., E-Comm. (4 cases)
Ratings
Experience
Grade
Trend
DCT
L4
C
PTAB
--
--
--
CAFC
--
--
--
Cases
Case # | Court | Caption | Filed | Represent |
|---|---|---|---|---|
| 1:24-CV-00940 | Astellas Pharma Inc v. Zydus Pharma USA Inc | 08/13/24 | Challenger | |
| 1:23-CV-00819 | Astellas Pharma Inc v. Lupin Ltd | 07/28/23 | ||
| 1:23-CV-00732 | Biogen Inc. v. Zydus Worldwide DMCC | 07/06/23 | Challenger | |
| 2:22-CV-04499 | Astellas Pharma Inc v. Zydus Pharma USA Inc | 07/08/22 | Challenger | |
| 1:22-CV-00297 | Novo Nordisk Inc. v. Zydus Worldwide DMCC | 03/04/22 | Challenger | |
| 1:22-CV-00294 | Novo Nordisk Inc v. Rio Biopharma Inc | 03/04/22 | ||
| 1:21-CV-01066 | Eden Biodesign LLC v. Cadila Healthcare | 07/23/21 | Challenger | |
| 1:21-CV-00315 | Merck Sharp & Dohme LLC v. Zydus Worldwide DMCC | 03/01/21 | Challenger | |
| 1:20-CV-01589 | Astellas Pharma Inc v. Sandoz Inc | 11/24/20 | ||
| 1:20-CV-01496 | Merck Sharp & Dohme Corp v. Ajanta Pharma Ltd | 11/04/20 |